References
- Rychik J, Atz AM, Celermajer DS, et al. Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation 2019;140:CIR0000000000000696.
- Yoon JK, Kim GB, Song MK, et al. Long-term outcome of Fontan-associated protein-losing enteropathy: treatment modality and predictive factor of mortality. Korean Circ J 2022;52:606-20.
- Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998;115:1063-73.
- John AS, Johnson JA, Khan M, Driscoll DJ, Warnes CA, Cetta F. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 2014;64:54-62.
- Schleiger A, Ovroutski S, Peters B, et al. Treatment strategies for protein-losing enteropathy in Fontan-palliated patients. Cardiol Young 2020;30:698-709.
- Sharma VJ, Iyengar AJ, Zannino D, et al. Protein-losing enteropathy and plastic bronchitis after the Fontan procedure. J Thorac Cardiovasc Surg 2021;161:2158-2165.e4.